Our goal is to maximize the reach and effectiveness of the medicines we create. By analyzing real-world evidence and optimizing clinical trials, we can discover new applications for our molecules, delivering effective therapies to patients more quickly.
Precision medicine is central to our approach. Advanced diagnostics, biomarker analysis and individual omics profiles help us tailor treatments, enhancing their effectiveness and patient outcomes.
We make clinical trials more accessible to patients, even those who live far from traditional trial sites. Our trials are designed to ensure study populations reflect real-world conditions. And we use AI and data analytics to design more efficient trials and identify participants who may benefit most from the investigational therapies we are exploring.
